Teva Pharmaceutical Industries
TEVA
39.23
+0.69
+1.79%
Teva Pharmaceutical Industries
US · TEVA
#471 by market cap
Listed 1970
39.23
+0.69
+1.79%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 13 analysts
Buy
Avg price target 51.54 +31.4%
Price target rangecurrent 39.23
Low45.94
Avg51.54
High57.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-19 | Leerink Partners | -- | Buy | -- |
| 2026-11-18 | Barclays | -- | Buy | 50.00 |
| 2026-11-17 | H.C. Wainwright | -- | Buy | 54.00 |
| 2026-11-16 | Argus Research | -- | Buy | 50.00 |
| 2026-11-12 | TD Cowen | -- | Buy | 57.00 |
| 2026-11-12 | Piper Sandler | -- | Buy | 56.00 |
| 2026-11-12 | Evercore | -- | Buy | -- |
| 2026-11-12 | H.C. Wainwright | -- | Buy | 54.00 |
| 2026-11-12 | Oppenheimer | -- | Buy | 54.00 |
| 2026-11-11 | BofA Securities | -- | Buy | 48.00 |
| 2026-11-04 | Scotiabank | -- | Buy | 47.00 |
| 2026-11-04 | Goldman Sachs | -- | Buy | 55.00 |
| 2026-11-04 | H.C. Wainwright | -- | Buy | 54.00 |
| 2026-11-04 | J.P. Morgan | -- | Buy | 50.00 |
| 2026-11-03 | BofA Securities | -- | Buy | 48.00 |
| 2026-11-03 | Scotiabank | -- | Buy | 47.00 |
| 2026-11-02 | H.C. Wainwright | -- | Buy | 52.00 |
| 2026-10-23 | Piper Sandler | -- | Buy | 44.00 |
| 2026-10-15 | Barclays | -- | Buy | 47.00 |
| 2026-10-12 | Scotiabank | -- | Buy | 47.00 |
| 2026-10-12 | Leader Capital Markets | -- | Buy | 45.94 |
| 2026-10-12 | Goldman Sachs | -- | Buy | 50.00 |
| 2026-10-12 | Barclays | -- | Buy | 42.00 |
| 2026-10-11 | J.P. Morgan | -- | Buy | 50.00 |
| 2026-10-09 | BofA Securities | -- | Buy | 43.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | -- | ±6.58% | +2.97% (in line) |
| 2026/Q2 | 2026-07-29 | -- | ±6.19% | +9.60% (beat) |
| 2026/Q1 | 2026-04-29 | -- | ±12.22% | +11.89% (in line) |
| 2025/Q4 | 2026-01-28 | -- | ±6.43% | +2.09% (in line) |
| 2025/Q3 | 2025-11-05 | -- | ±6.14% | +20.23% (beat) |
| 2025/Q2 | 2025-07-30 | -- | ±8.15% | +1.75% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±9.79% | +9.18% (in line) |
| 2024/Q4 | 2025-01-29 | -- | ±7.94% | -13.89% (beat) |
| 2024/Q3 | 2024-11-06 | -- | ±7.99% | -7.14% (in line) |
| 2024/Q2 | 2024-07-31 | -- | ±10.41% | +6.22% (in line) |
| 2024/Q1 | 2024-05-08 | -- | ±7.44% | +12.83% (beat) |
| 2023/Q4 | 2024-01-31 | -- | ±9.30% | +3.15% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:01:26 · For reference only, not investment advice and not tailored to your situation.
Teva Pharmaceutical Industries discussion 0 comments